INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,858 Cr | ₹1,592 Cr | ₹1,329 Cr | ₹748 Cr | ₹612 Cr |
What is the latest Total Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,858 Cr |
| Mar2025 | ₹1,592 Cr |
| Mar2024 | ₹1,329 Cr |
| Mar2023 | ₹748 Cr |
| Mar2022 | ₹612 Cr |
How is Total Liabilities of INNOVA CAPTAB Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,858 Cr | 16.74 | |
| Mar2025 | ₹1,592 Cr | 19.72 | |
| Mar2024 | ₹1,329 Cr | 77.68 | |
| Mar2023 | ₹748 Cr | 22.22 | |
| Mar2022 | ₹612 Cr | - | |
Compare Total Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹6,192.5 Cr | 4.6% | 11.1% | 15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 4.6% |
11.1% |
15.3% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses